Dec 03, 2024 Is the SEC Cracking Down on Life Science Companies Misleading Investors? By Merritt Steele On December 3, the U.S. Securities and Exchange Commission settled charges against biotherapeutics company Kiromic BioPharma, Inc., its...
Dec 03, 2024 Your 2024 Proxy Season Debrief from Silicon Valley and Beyond By Wendy Grasso David Bell Over the last five years, stockholder activism has undergone significant transformation, shaped by changing market conditions, regulatory...
Dec 03, 2024 How to Use the DOJ ECCP to Bolster Your Compliance Program By Merritt Steele In September, the U.S. Department of Justice updated its Evaluation of Corporate Compliance Programs (ECCP) guidance, which is the...
Nov 27, 2024 New Structured Data Requirement for Schedules 13D/13G Takes Effect Dec. 18 By Merritt Steele Beginning December 18, Schedules 13D and 13G must be filed using an XML-based language. Filers will have the option of (1) using a...
Nov 21, 2024 ISS Analyzes Trends in Corporate Political Activity Disclosures and Related Shareholder Proposals Over the Past Decade By Wendy Grasso Institutional Shareholder Services (ISS) recently reported on trends in corporate political activity disclosures and related shareholder...
Nov 19, 2024 Upcoming FDA Meeting Focuses on Generative AI in Medical Devices By Jefferson Lin The U.S. Food and Drug Administration will focus on “Total Product Lifecycle Considerations for Generative AI-Enabled Devices” during its...
Nov 19, 2024 Accenture Report Reveals World’s Largest Companies Making Meaningful Progress Toward Net Zero, But Progress Is Not Fast Enough By Wendy Grasso Last week global professional services firm Accenture published its fourth annual Destination Net Zero report, in which it examined the...
Nov 19, 2024 Glass Lewis Releases 2025 Benchmark Policy Guidelines By Wendy Grasso Last Thursday, proxy advisory firm Glass Lewis released its 2025 Proxy Voting Policy Guidelines 2025 U.S. Benchmark Policy Guidelines,...
Nov 18, 2024 Update on New USPTO Rules for Practice Before the Patent Trial and Appeal Board By Jennifer Bush The U.S. Patent and Trademark Office (USPTO) has implemented three new rules impacting practice before the Patent Trial and Appeal Board...
Nov 18, 2024 DARPA Extends Submission Deadline for RFI By Patrick Grilli Zohra Tejani Important opportunity for investors in the defense innovation and dual-use technology sectors! The Defense Advanced Research Projects...
Nov 15, 2024 Out of This World: Space Logistics Present New Govt. Contracting Opportunities By Patrick Grilli The U.S. Department of Defense (DoD) is turning to commercial space companies to solve logistical challenges, prioritizing reentry...
Nov 15, 2024 Fifth Circuit Rejects Challenge to SEC Rule 14a-8 No-Action Letter By Wendy Grasso Public companies can breathe a sigh of relief, at least for now, that the Securities and Exchange Commission's 14a-8 regulatory process...